TY - JOUR
T1 - The history of antiretroviral therapy and of its implementation in resource-limited areas of the world
AU - Vella, Stefano
AU - Schwartländer, Bernard
AU - Sow, Salif Papa
AU - Eholie, Serge Paul
AU - Murphy, Robert L.
PY - 2012/6/19
Y1 - 2012/6/19
N2 - HIV/AIDS not only represents the most severe epidemic in modern times, but also the greatest public health challenge in history. The response of the scientific community has been impressive and in just a few years, turned an inevitably fatal disease into a chronic manageable although not yet curable condition. The development of antiretroviral therapy is not only the history of scientific advancements: it is the result of the passionate 'alliance' towards a common goal between researchers, doctors and nurses, pharmaceutical industries, regulators, public health officials and the community of HIV-infected patients, which is rather unique in the history of medicine. In addition, the rapid and progressive development of antiretroviral therapy has not only proven to be life-saving for many millions but has been instrumental in unveiling the inequities in access to health between rich and poor countries of the world. Optimal benefits indeed, are not accessible to all people living with HIV, with challenges to coverage and sustainability in low and middle income countries. This paper will review the progress made, starting from the initial despairing times, till the current battle towards universal access to treatment and care for all people living with HIV.
AB - HIV/AIDS not only represents the most severe epidemic in modern times, but also the greatest public health challenge in history. The response of the scientific community has been impressive and in just a few years, turned an inevitably fatal disease into a chronic manageable although not yet curable condition. The development of antiretroviral therapy is not only the history of scientific advancements: it is the result of the passionate 'alliance' towards a common goal between researchers, doctors and nurses, pharmaceutical industries, regulators, public health officials and the community of HIV-infected patients, which is rather unique in the history of medicine. In addition, the rapid and progressive development of antiretroviral therapy has not only proven to be life-saving for many millions but has been instrumental in unveiling the inequities in access to health between rich and poor countries of the world. Optimal benefits indeed, are not accessible to all people living with HIV, with challenges to coverage and sustainability in low and middle income countries. This paper will review the progress made, starting from the initial despairing times, till the current battle towards universal access to treatment and care for all people living with HIV.
KW - AIDS
KW - HIV
KW - antiretroviral therapy
KW - resource-limited settings
UR - http://www.scopus.com/inward/record.url?scp=84862732933&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862732933&partnerID=8YFLogxK
U2 - 10.1097/QAD.0b013e32835521a3
DO - 10.1097/QAD.0b013e32835521a3
M3 - Review article
C2 - 22706009
AN - SCOPUS:84862732933
SN - 0269-9370
VL - 26
SP - 1231
EP - 1241
JO - AIDS
JF - AIDS
IS - 10
ER -